AKT1 and type 2 diabetes mellitus: Recent studies have clarified that numerous metabolites of TCM addressing complex and comprehensive targets have the potential for hypoglycemic effect in T2DM by regulating the PI3K/AKT signaling pathway (Nurcahyanti et al., 2021).